Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma

Condition:   Nasopharyngeal Carcinoma
Interventions:   Radiation: Intensity-modulated radiation therapy;   Drug: Paclitaxel liposome;   Drug: Cisplatin;   Drug: 5-Fluorouracil
Sponsor:   Sun Yat-sen University
Not yet recruiting

https://ift.tt/2CPY4Hd